ArticleCureus2026
Hydatid Pulmonary Embolism Complicating Hepatopulmonary Hydatid Disease: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hydatid disease is an endemic parasitic infection that primarily affects the liver and lungs. Hydatid pulmonary embolism is an exceptional and potentially severe complication, usually resulting from the rupture of a hydatid cyst into the venous circulation. We report the case of a 64-year-old patient, a former smoker from a rural area, who had been diagnosed with hepatopulmonary hydatid disease complicated by chronic bilateral hydatid pulmonary embolism two years before the current admission. Echinococcosis serology was positive. Thoracic computed tomography (CT) angiography revealed arterial hydatid involvement associated with multiple pulmonary and hepatic cystic lesions. Management included therapeutic anticoagulation, empirical antibiotics, and the cautious reintroduction of albendazole with close biological monitoring, followed by hepatic surgery. Pulmonary embolism is a rare presentation of hydatid disease. Because of its nonspecific clinical features, careful diagnostic assessment and individualized management are required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.